Stratton MR - Search Results

1

Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations.

Lakhani SR, Slack DN, Hamoudi RA, Collins N, Stratton MR, Sloane JP. Lakhani SR, et al. Among authors: stratton mr. Lab Invest. 1996 Jan;74(1):129-35. Lab Invest. 1996. PMID: 8569175

2

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.

Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, Hamoudi R, van Rensburg EJ, Dunning AM, Love R, Evans G, Easton D, Clayton D, Stratton MR, Ponder BA. Gayther SA, et al. Among authors: stratton mr. Nat Genet. 1995 Dec;11(4):428-33. doi: 10.1038/ng1295-428. Nat Genet. 1995. PMID: 7493024

3

Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.

Lakhani SR, Collins N, Stratton MR, Sloane JP. Lakhani SR, et al. Among authors: stratton mr. J Clin Pathol. 1995 Jul;48(7):611-5. doi: 10.1136/jcp.48.7.611. J Clin Pathol. 1995. PMID: 7560165 Free PMC article.

4

Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.

Cleton-Jansen AM, Collins N, Lakhani SR, Weissenbach J, Devilee P, Cornelisse CJ, Stratton MR. Cleton-Jansen AM, et al. Among authors: stratton mr. Br J Cancer. 1995 Nov;72(5):1241-4. doi: 10.1038/bjc.1995.493. Br J Cancer. 1995. PMID: 7577475 Free PMC article.

5

Loss of heterozygosity in ductal carcinoma in situ of the breast.

Stratton MR, Collins N, Lakhani SR, Sloane JP. Stratton MR, et al. J Pathol. 1995 Feb;175(2):195-201. doi: 10.1002/path.1711750207. J Pathol. 1995. PMID: 7738715

6

Molecular analyses of in situ breast cancer.

Stratton MR, Collins N, Lakhani S, Sloane J. Stratton MR, et al. Eur J Cancer Prev. 1993 Nov;2 Suppl 3:123. Eur J Cancer Prev. 1993. PMID: 7905313 No abstract available.

7

Terminology for carcinoma-in-situ of the breast.

Sloane JP, Lakhani SR, Stratton MR. Sloane JP, et al. Among authors: stratton mr. Lancet. 1996 May 4;347(9010):1259-60. Lancet. 1996. PMID: 8622469 No abstract available.

8

BRCA2 mutations in primary breast and ovarian cancers.

Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR, Futreal PA. Lancaster JM, et al. Among authors: stratton mr. Nat Genet. 1996 Jun;13(2):238-40. doi: 10.1038/ng0696-238. Nat Genet. 1996. PMID: 8640235

9

The cylindromatosis gene (cyld1) on chromosome 16q may be the only tumour suppressor gene involved in the development of cylindromas.

Biggs PJ, Chapman P, Lakhani SR, Burn J, Stratton MR. Biggs PJ, et al. Among authors: stratton mr. Oncogene. 1996 Mar 21;12(6):1375-7. Oncogene. 1996. PMID: 8649842

10

Screening for ESR mutations in breast and ovarian cancer patients.

Anderson TI, Wooster R, Laake K, Collins N, Warren W, Skrede M, Elles R, Tveit KM, Johnston SR, Dowsett M, Olsen AO, Møller P, Stratton MR, Børresen-Dale AL. Anderson TI, et al. Among authors: stratton mr. Hum Mutat. 1997;9(6):531-6. doi: 10.1002/(SICI)1098-1004(1997)9:6<531::AID-HUMU6>3.0.CO;2-4. Hum Mutat. 1997. PMID: 9195227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters